Natixis’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.7M | Buy |
66,593
+11,114
| +20% | +$6.03M | 0.12% | 128 |
|
|
2025
Q4 | $32.1M | Sell |
55,479
-126,945
| -70% | -$71.8M | 0.11% | 127 |
|
|
2025
Q3 | $88.5M | Buy |
182,424
+124,641
| +216% | +$58M | 0.41% | 37 |
|
|
2025
Q2 | $23.4M | Buy |
57,783
+32,396
| +128% | +$13.5M | 0.1% | 131 |
|
|
2025
Q1 | $12.5M | Sell |
25,387
-8,903
| -26% | -$4.82M | 0.07% | 194 |
|
|
2024
Q4 | $17.8M | Sell |
34,290
-25,811
| -43% | -$14.2M | 0.11% | 146 |
|
|
2024
Q3 | $37.2M | Buy |
60,101
+39,474
| +191% | +$23.4M | 0.21% | 84 |
|
|
2024
Q2 | $11.4M | Buy |
20,627
+19,198
| +1,343% | +$11M | 0.07% | 192 |
|
|
2024
Q1 | $831K | Sell |
1,429
-178,765
| -99% | -$100M | ﹤0.01% | 558 |
|
|
2023
Q4 | $95.6M | Buy |
180,194
+148,609
| +471% | +$71.9M | 0.69% | 21 |
|
|
2023
Q3 | $16M | Sell |
31,585
-8,174
| -21% | -$4.36M | 0.12% | 147 |
|
|
2023
Q2 | $20.7M | Buy |
39,759
+23,919
| +151% | +$12.9M | 0.17% | 122 |
|
|
2023
Q1 | $9.13M | Sell |
15,840
-72,761
| -82% | -$41M | 0.08% | 202 |
|
|
2022
Q4 | $48.8M | Buy |
88,601
+18,601
| +27% | +$9.86M | 0.27% | 90 |
|
|
2022
Q3 | $35.5M | Sell |
70,000
-23,203
| -25% | -$13M | 0.17% | 96 |
|
|
2022
Q2 | $50.5M | Sell |
93,203
-23,016
| -20% | -$12.7M | 0.18% | 72 |
|
|
2022
Q1 | $68.6M | Buy |
116,219
+30,514
| +36% | +$17.5M | 0.24% | 87 |
|
|
2021
Q4 | $57.2M | Sell |
85,705
-21,820
| -20% | -$13.6M | 0.2% | 92 |
|
|
2021
Q3 | $61.4M | Buy |
+107,525
| New | +$59M | 0.21% | 92 |
|
|
2021
Q2 | – | Sell |
-146,444
| Closed | -$66.8M | – | 1032 |
|
|
2021
Q1 | $66.8M | Sell |
146,444
-39,172
| -21% | -$18.7M | 0.22% | 99 |
|
|
2020
Q4 | $86.5M | Buy |
185,616
+96,856
| +109% | +$45.4M | 0.31% | 66 |
|
|
2020
Q3 | $39.2M | Buy |
88,760
+65,800
| +287% | +$27.2M | 0.29% | 88 |
|
|
2020
Q2 | $8.32M | Sell |
22,960
-104,104
| -82% | -$34.9M | 0.06% | 216 |
|
|
2020
Q1 | $36M | Sell |
127,064
-6,625
| -5% | -$2.09M | 0.28% | 78 |
|
|
2019
Q4 | $43.5M | Buy |
+133,689
| New | +$40.5M | 0.27% | 102 |
|
|
2019
Q3 | – | Sell |
-237,458
| Closed | -$69.7M | – | 919 |
|
|
2019
Q2 | $69.7M | Buy |
237,458
+184,420
| +348% | +$50.8M | 0.54% | 44 |
|
|
2019
Q1 | $14.3M | Sell |
53,038
-87,434
| -62% | -$21.8M | 0.09% | 214 |
|
|
2018
Q4 | $31.4M | Sell |
140,472
-603,336
| -81% | -$142M | 0.26% | 103 |
|
|
2018
Q3 | $182M | Buy |
743,808
+397,051
| +115% | +$91.3M | 1.05% | 16 |
|
|
2018
Q2 | $71.8M | Buy |
346,757
+265,699
| +328% | +$56.4M | 0.38% | 72 |
|
|
2018
Q1 | $16.7M | Buy |
81,058
+72,854
| +888% | +$15.3M | 0.1% | 203 |
|
|
2017
Q4 | $1.56M | Sell |
8,204
-15,293
| -65% | -$2.93M | 0.01% | 436 |
|
|
2017
Q3 | $4.45M | Sell |
23,497
-94,176
| -80% | -$17.1M | 0.04% | 288 |
|
|
2017
Q2 | $20.5M | Buy |
117,673
+109,017
| +1,259% | +$18.3M | 0.23% | 108 |
|
|
2017
Q1 | $1.33M | Sell |
8,656
-21,460
| -71% | -$3.28M | 0.02% | 358 |
|
|
2016
Q4 | $4.25M | Buy |
+30,116
| New | +$4.44M | 0.04% | 273 |
|
|
2015
Q2 | – | Sell |
-2,708
| Closed | -$364K | – | 447 |
|
|
2015
Q1 | $364K | Sell |
2,708
-398
| -13% | -$51.3K | 0.01% | 335 |
|
|
2014
Q4 | $389K | Buy |
3,106
+595
| +24% | +$72.3K | 0.01% | 310 |
|
|
2014
Q3 | $306K | Buy |
+2,511
| New | +$305K | ﹤0.01% | 349 |
|
|
2014
Q2 | – | Sell |
-4,980
| Closed | -$599K | – | 525 |
|
|
2014
Q1 | $599K | Sell |
4,980
-218,355
| -98% | -$26M | 0.01% | 351 |
|
|
2013
Q4 | $24.9M | Buy |
+223,335
| New | +$22.2M | 0.21% | 101 |
|
Other funds holding TMO
VCM
Natixis's TMO Position: Q1 2026 in Review
Natixis increased its Thermo Fisher Scientific (TMO) stake by 20% in Q1 2026, buying an estimated $6.03M and bringing the position to 66,593 shares worth $32.7M. The position accounts for 0.12% of the portfolio, ranked #128.
Natixis first reported a position in TMO in Q4 2013 and has held it in 41 quarters since. The position peaked at $182M in Q3 2018. 2,596 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Natixis held 66,593 shares of Thermo Fisher Scientific worth $32.7M as of Q1 2026.
- Natixis bought 11,114 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.03M.
- Thermo Fisher Scientific made up 0.12% of Natixis's portfolio in Q1 2026, its #128 holding.
- Natixis first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 41 quarters since.
- Natixis's Thermo Fisher Scientific position peaked at $182M in Q3 2018.
- 2,596 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.